WellSense Health Plan

Does WellSense Health Plan cover Mounjaro?

Quick answer · Type 2 Diabetes

WellSense Health Plan covers Mounjaro for type 2 diabetes with prior authorization on Employer / Commercial Insurance and ACA Marketplace.

  • Employer / Commercial Insurance: Covered with requirements. Diagnosis documented with a code
  • ACA Marketplace: Covered with requirements. Diagnosis documented with a code

Last verified June 10, 2026. Policy effective January 1, 2026. Source: policy-445.html. How we verify this data →

Check your card for your exact plan →

Mounjaro for Type 2 Diabetes

What WellSense Health Plan requires, by plan type. Open this indication on its own page →

Employer / Commercial Insurance

Covered with requirements

What you need to qualify

  • Age 18 and older
  • Diagnosis documented with a code

Qualification pathways

You can qualify through any one of these.

Initial approval for Type 2 Diabetes

All of:

  • Diagnosis of Type 2 Diabetes Mellitus confirmed by documentation (medical records, chart notes, A1C, ICD-10 code)
  • Inadequate response within the past 130 days, adverse reaction, or contraindication to a formulary covered oral agent for T2DM (Appendix A)
  • Member is not using multiple GLP-1 agents
  • Member is at least 18 years of age

Reauthorization for Type 2 Diabetes

All of:

  • Diagnosis of Type 2 Diabetes Mellitus confirmed by documentation (medical records, chart notes, A1C, ICD-10 code)
  • Inadequate response, adverse reaction, or contraindication to a formulary covered oral agent for T2DM (Appendix A)
  • Member is not using multiple GLP-1 agents
  • Member is at least 18 years of age

Plus any one of:

  • Positive clinical response to therapy
  • Documentation of clinical justification to continue therapy with requested medication

Documentation to bring

  • Documentation confirming Type 2 Diabetes Mellitus diagnosis (medical records, chart notes, A1C result, or ICD-10 code)
  • Documentation of inadequate response within the past 130 days, adverse reaction, or contraindication to a formulary covered oral agent for T2DM (Appendix A)

Approval and renewal

  • Initial approval: 12 months
  • Renewal: every 12 months
  • To renew, the plan looks for Positive clinical response to therapy OR documentation of clinical justification to continue therapy with requested medication.

Not covered when

  • Member must not be using multiple GLP-1 agents simultaneously
  • Type 1 diabetes

Policy note: Covered use stated as 'all medically accepted indications unless otherwise excluded.' Step therapy requires inadequate response, adverse reaction, or contraindication to a formulary covered oral agent from Appendix A (includes metformin combinations, sulfonylureas, DPP-4 inhibitors, SGLT2 inhibitors, thiazolidinediones, meglitinides, and alpha-glucosidase inhibitors). The 130-day lookback period for oral agent trial applies to initial authorization only. Requirements may adjudicate at point of service if satisfied via automated record search. Victoza (liraglutide) is listed as a product affected but was moved to non-formulary (NF) per version 5.0 revision notes.

Policy effective January 1, 2026 · verified June 10, 2026 · source: policy-445.html

ACA Marketplace

Covered with requirements

What you need to qualify

  • Age 18 and older
  • Diagnosis documented with a code

Qualification pathways

You can qualify through any one of these.

Initial approval for Type 2 Diabetes

All of:

  • Diagnosis of Type 2 Diabetes Mellitus confirmed by documentation (medical records, chart notes, A1C, ICD-10 code)
  • Inadequate response within the past 130 days, adverse reaction, or contraindication to a formulary covered oral agent for T2DM (Appendix A)
  • Member is not using multiple GLP-1 agents
  • Member is at least 18 years of age

Reauthorization for Type 2 Diabetes

All of:

  • Diagnosis of Type 2 Diabetes Mellitus confirmed by documentation (medical records, chart notes, A1C, ICD-10 code)
  • Inadequate response, adverse reaction, or contraindication to a formulary covered oral agent for T2DM (Appendix A)
  • Member is not using multiple GLP-1 agents
  • Member is at least 18 years of age

Plus any one of:

  • Positive clinical response to therapy
  • Documentation of clinical justification to continue therapy with requested medication

Documentation to bring

  • Documentation confirming Type 2 Diabetes Mellitus diagnosis (medical records, chart notes, A1C result, or ICD-10 code)
  • Documentation of inadequate response within the past 130 days, adverse reaction, or contraindication to a formulary covered oral agent for T2DM (Appendix A)

Approval and renewal

  • Initial approval: 12 months
  • Renewal: every 12 months
  • To renew, the plan looks for Positive clinical response to therapy OR documentation of clinical justification to continue therapy with requested medication.

Not covered when

  • Member must not be using multiple GLP-1 agents simultaneously
  • Type 1 diabetes

Policy note: Covered use stated as 'all medically accepted indications unless otherwise excluded.' Step therapy requires inadequate response, adverse reaction, or contraindication to a formulary covered oral agent from Appendix A (includes metformin combinations, sulfonylureas, DPP-4 inhibitors, SGLT2 inhibitors, thiazolidinediones, meglitinides, and alpha-glucosidase inhibitors). The 130-day lookback period for oral agent trial applies to initial authorization only. Requirements may adjudicate at point of service if satisfied via automated record search. Victoza (liraglutide) is listed as a product affected but was moved to non-formulary (NF) per version 5.0 revision notes.

Policy effective January 1, 2026 · verified June 10, 2026 · source: policy-445.html

Why Mounjaro requests get denied by WellSense Health Plan

Based on what this policy asks for. Fix these before the first submission.

  1. Wrong brand for the diagnosis. Mounjaro and Zepbound are the same molecule with different approved uses; a request for Mounjaro under a diagnosis that matches Zepbound is routinely denied.
  2. Diagnosis code missing or wrong on the request.

Frequently asked questions

Does WellSense Health Plan cover Mounjaro?
WellSense Health Plan covers Mounjaro for type 2 diabetes with prior authorization on Employer / Commercial Insurance and ACA Marketplace.
How long does a Mounjaro approval last with WellSense Health Plan?
Initial approvals last 12 months, and renewals are granted in 12-month periods.
What does WellSense Health Plan require to renew Mounjaro?
Positive clinical response to therapy OR documentation of clinical justification to continue therapy with requested medication.
How current is this information?
This page reflects WellSense Health Plan's written policy as of January 1, 2026, last verified against the source document on June 10, 2026.

Other medications under WellSense Health Plan

Mounjaro coverage under other plans

All insurance plans · All medications

This page summarizes WellSense Health Plan's written prior-authorization policy. It is not a guarantee of coverage; plans vary by employer and benefit design. Verify with your plan before relying on it.